ATE64527T1 - Verfahren zur herstellung von vitaminpraeparaten. - Google Patents

Verfahren zur herstellung von vitaminpraeparaten.

Info

Publication number
ATE64527T1
ATE64527T1 AT87105082T AT87105082T ATE64527T1 AT E64527 T1 ATE64527 T1 AT E64527T1 AT 87105082 T AT87105082 T AT 87105082T AT 87105082 T AT87105082 T AT 87105082T AT E64527 T1 ATE64527 T1 AT E64527T1
Authority
AT
Austria
Prior art keywords
manufacture
vitamin preparations
preparations
beadlets
carotenoids
Prior art date
Application number
AT87105082T
Other languages
English (en)
Inventor
Leonard Joseph Scialpi
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8196899&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE64527(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE64527T1 publication Critical patent/ATE64527T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT87105082T 1987-04-06 1987-04-06 Verfahren zur herstellung von vitaminpraeparaten. ATE64527T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP87105082A EP0285682B2 (de) 1987-04-06 1987-04-06 Verfahren zur Herstellung von Vitaminpräparaten

Publications (1)

Publication Number Publication Date
ATE64527T1 true ATE64527T1 (de) 1991-07-15

Family

ID=8196899

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87105082T ATE64527T1 (de) 1987-04-06 1987-04-06 Verfahren zur herstellung von vitaminpraeparaten.

Country Status (3)

Country Link
EP (1) EP0285682B2 (de)
AT (1) ATE64527T1 (de)
DE (1) DE3770940D1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5043170A (en) * 1989-02-14 1991-08-27 Hoffmann-La Roche Inc. Animal feed composition containing a vitamin D metabolite
US5234695A (en) * 1990-07-24 1993-08-10 Eastman Kodak Company Water dispersible vitamin E composition
DE4141351A1 (de) * 1991-12-14 1993-06-17 Basf Ag Stabile pulverfoermige vitamin- und/oder carotinoid-praeparate und verfahren zu deren herstellung
DE4221880A1 (de) * 1992-07-03 1994-01-05 Alfatec Pharma Gmbh Feste und flüssige Lösungen von schwer wasserlöslichen Arzneistoffen
US5270063A (en) * 1992-08-03 1993-12-14 Kellogg Company Ready-to-eat cereal products enriched with beta-carotene
FR2703263B1 (fr) 1993-03-31 1995-05-19 Rhone Poulenc Nutrition Animal Procédé de préparation de sphérules de principes actifs.
FR2707184B1 (fr) * 1993-07-08 1995-08-11 Rhone Poulenc Nutrition Animal Procédé de préparation de sphérules contenant un principe actif alimentaire ou pharmaceutique.
US5532009A (en) * 1995-06-07 1996-07-02 The Procter & Gamble Company Fat substitutes containing water soluble beta-carotene
DE19642359A1 (de) 1996-10-14 1998-04-16 Basf Ag Stabile Emulsionen und Trockenpulver von Mischungen fettlöslicher Vitamine, deren Herstellung und Verwendung
US6444227B1 (en) * 1999-08-05 2002-09-03 Roche Vitamins Inc. Process for preparing fat soluble beadlets
CN1240438C (zh) * 1999-12-23 2006-02-08 安迪苏法国联合股份有限公司 颗粒状维生素组合物
WO2003017785A1 (en) * 2001-08-23 2003-03-06 Dsm Ip Assets B.V. Novel stabilized carotenoid compositions
JP4773337B2 (ja) 2003-03-27 2011-09-14 ディーエスエム アイピー アセッツ ビー．ブイ． ビーズレットの製造方法
US10463061B2 (en) 2004-11-19 2019-11-05 Dsm Ip Assets B.V. Modified plant gums for preparations of active ingredients
RU2290173C2 (ru) * 2005-04-04 2006-12-27 Открытое акционерное общество "Научно-исследовательский институт технологий медицинской промышленности" (ОАО"НИИ ТМП") Способ получения стабильных сухих порошков жирорастворимых витаминов или каротиноидов
EP2210593A3 (de) 2009-01-21 2011-05-18 DSM IP Assets B.V. Tablettierbare Formulierungen von Vitamin A und Derivate davon
FR2953409B1 (fr) 2009-12-09 2011-12-23 Adisseo France Sas Particules de principes actifs liposolubles stables
EP2532354A1 (de) 2011-06-08 2012-12-12 OrganoBalance GmbH Sprühgetrocknete Lactobacillus Stämme / Zellen und deren Verwendung gegen Helicobacter Pylori
US20140147427A1 (en) 2011-06-08 2014-05-29 Organobalance Gmbh Spray-Dried Lactobacillus Stems/Cells and the Use of Same Against Helicobacter Pylori
EP3437488B8 (de) * 2016-03-30 2021-03-17 Riken Vitamin Co., Ltd. Carotinoidhaltige partikel
GB201911925D0 (en) 2019-08-20 2019-10-02 Sporegen Ltd Formulations for prevention or reduction of c. difficile infections
FR3111051A1 (fr) 2020-06-05 2021-12-10 Adisseo France S.A.S. Formulation de vitamine a
WO2022112585A1 (en) * 2020-11-30 2022-06-02 Dsm Ip Assets B.V. New sugar-free formulations, their manufacture and use
EP4250959A1 (de) * 2020-11-30 2023-10-04 DSM IP Assets B.V. Neue formulierungen mit reduziertem antioxidantgehalt, ihre herstellung und verwendung
EP4250961A1 (de) * 2020-11-30 2023-10-04 DSM IP Assets B.V. Neue formulierungen mit reduziertem antioxidantgehalt, ihre herstellung und verwendung
WO2022038588A2 (en) 2021-12-23 2022-02-24 Novozymes A/S Process for producing dried lactobacillus cells
EP4680205A1 (de) 2023-03-14 2026-01-21 DSM IP Assets B.V. Cannabinoidformulierungen
EP4680204A1 (de) 2023-03-14 2026-01-21 DSM IP Assets B.V. Cannabinoidformulierungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2756177A (en) * 1953-03-09 1956-07-24 Hoffmann La Roche Process for making fat-soluble vitamin active powder
FR1287716A (fr) * 1960-04-07 1962-03-16 Philips Nv Procédé de préparation d'un produit sec épandable, contenant une substance biologique active
US3749799A (en) * 1972-02-04 1973-07-31 Hoffmann La Roche Stable dry vitamin a preparations

Also Published As

Publication number Publication date
EP0285682A1 (de) 1988-10-12
EP0285682B2 (de) 1997-08-06
DE3770940D1 (de) 1991-07-25
EP0285682B1 (de) 1991-06-19

Similar Documents

Publication Publication Date Title
ATE64527T1 (de) Verfahren zur herstellung von vitaminpraeparaten.
DE3675796D1 (de) Verfahren zur herstellung von entschleimten pflanzlichen oelen und schleim mit hohem gehalt an phosphatidischer saeure.
DE3789435D1 (de) Verfahren zur Herstellung von Eicosapentaensäure.
DE69224124D1 (de) Verfahren zur Herstellung von Dihomo-Gamma-Linolensäure und das in dieser enthaltende Lipid
DE3778699D1 (de) Verwendung von vitamin e zur herstellung von arzneimitteln zur normalisierung der blutgerinnung bei therapie mit hochungesaettigten fettsaeuren vom omega-3-typ.
DE3762630D1 (de) Verfahren zur herstellung von diperoxidodecandionsaeure enthaltenden agglomeraten und die verwendung derselben in bleichmitteln.
DE3382156D1 (de) Verwendung von 8-substituierten guanosinderivaten enthaltenden zusammensetzungen zur herstellung von arzneimitteln.
ATA243992A (de) Verfahren zur herstellung von zur selektiven senkung des blutlipoidspiegels geeigneten arzneimittelpräparaten
DE58906574D1 (de) Verfahren zur Herstellung von cyclischen Kohlensäureestern.
DE3884870D1 (de) Verfahren zur Herstellung von Vitamin-D-Derivaten.
DE3784392D1 (de) Verfahren zur herstellung von eine oelloesliche substanz enthaltenden festen produkten.
ATE71658T1 (de) Verfahren zur herstellung von humanlysozym.
ATE77239T1 (de) Zubereitung zur stimulation der chondrozyten und des osteoblastes (ossein-hydroxyapatitverbindung), verfahren zur herstellung und pharmazeutische produkten, die sie enthalten.
PT87232A (pt) Process for the preparation of crosslinked porous skinless particles of pvc resin
PT81875B (de) Verfahren zur herstellung von 13beta-alkyl-milbemycinderivaten und verfahren zur bekampfung von parasiten an tieren und pflanzen
DE3886213D1 (de) Verfahren zur Herstellung von Antioxidant-Zubereitungen.
AU2072088A (en) Agent containing salicylic acid for treating lepidosis
ATA294581A (de) Verfahren zur herstellung von karamelpraeparaten in gepulverter form
DE58903882D1 (de) Muttersteckerteil zur gleichzeitigen herstellung von stark- und schwachstrom-steckverbindungen.
IE44288L (en) Preparation of amino acid mixture.
ATE41740T1 (de) Verfahren zur retardierung von vitamin c und e.
DE3888307D1 (de) Verfahren zur Herstellung von Ascorbinsäure-2-phosphat.
DE3689174D1 (de) Verfahren zur Herstellung von Riboflavin.
DE3884324D1 (de) Verfahren zur Herstellung von menschlichen pro-apolipoprotein-A-I-ähnlichen Proteinen.
AT344885B (de) Verfahren zur herstellung von 18-arabinosyl-2-n-butyl-3,7,11,15,19,21,23,25,27,37-dekahydroxy-4,16,32,34,36-pentamethyl-tetrakonta-16,32-dien-35-o-lacton-40-guanidiniumsulfat(debrycin) enthaltenden pharmazeutischen praeparaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee